trimetazidine has been researched along with Cardiac Remodeling, Ventricular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Guieu, R; Maixent, JM; Paganelli, F; Pierre, SV; Sadrin, S | 1 |
| He, J; Jin, C; Li, Y; Luan, Y; Wang, M; Wu, L; Zhang, W | 1 |
| Gong, W; Li, A; Ma, Y; Nie, S; Shi, H | 1 |
| Guo, T; Wang, J | 1 |
| Chen, A; Chen, M; Chen, X; Dai, W; Dong, Q; Li, W; Li, X; Ou, C; Shen, Y | 1 |
| Tang, WH | 1 |
| Barsotti, A; Di Napoli, P | 1 |
| Shen, JX; Wang, F; Wang, YM; Yu, P; Zhang, RY | 1 |
| Domergue-Dupont, V; Grynberg, A; Liao, R; Mouquet, F; Rousseau, D | 1 |
| Gao, D; Hao, G; Meng, Z; Ning, N; Niu, X | 1 |
| Ge, J; Jiang, H; Lu, Y; Sun, A; Zhang, L; Zou, Y | 1 |
| Chen, J; Li, C; Xu, W; Zhou, X | 1 |
| Aleksandriia, LG; Moiseev, VS; Tereshchenko, SN | 1 |
| Barbarash, LS; Kokov, AN; Tarasov, II | 1 |
5 review(s) available for trimetazidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Metabolic remodeling in chronic heart failure.
Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Carnitine; Energy Metabolism; Fatty Acids; Fetal Heart; Glucose; Heart Failure; Humans; Neurotransmitter Agents; Thiamine; Trimetazidine; Ventricular Remodeling | 2013 |
The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
Topics: Glucagon-Like Peptide 1; Heart Failure; Humans; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2009 |
Prognostic relevance of metabolic approach in patients with heart failure.
Topics: Heart Failure; Humans; Prognosis; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
Topics: Acetyl-CoA C-Acyltransferase; Adult; Chronic Disease; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Humans; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2011 |
Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
Topics: Disease Progression; Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2012 |
3 trial(s) available for trimetazidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Cardiovascular Agents; China; Coronary Artery Disease; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recovery of Function; Time Factors; Treatment Outcome; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2020 |
[Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diuretics; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Fibrinolytic Agents; Follow-Up Studies; Hemodynamics; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
[Trimetazidine effects on postinfarction remodeling of the left ventricle].
Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Streptokinase; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2005 |
6 other study(ies) available for trimetazidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of long-term anti-ischemic drug treatment on Na,K-ATPase isoforms in cardiomyopathic hamsters.
Topics: Animals; Blotting, Western; Cardiomyopathies; Cricetinae; Heart; Ischemia; Isoenzymes; Male; Mesocricetus; Myocardium; Sodium-Potassium-Exchanging ATPase; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2021 |
Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Topics: Animals; Antioxidants; Cell Line; Disease Models, Animal; Down-Regulation; Heart Rupture, Post-Infarction; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Aorta, Abdominal; Arterial Pressure; Cardiovascular Agents; Constriction; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Myocardium; Neuropeptide Y; Oxidative Stress; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Signal Transduction; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2016 |
[Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
Topics: Animals; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Male; Myocardial Infarction; Rats; Rats, Wistar; RNA, Messenger; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.
Topics: Animals; Data Interpretation, Statistical; Disease Models, Animal; Fatty Acids; Male; Myocardial Infarction; Myocardial Reperfusion; Oxidation-Reduction; Rats; Rats, Wistar; Survival Analysis; Trimetazidine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cytokines; Drug Evaluation, Preclinical; Gene Expression Regulation; Inflammation; Inflammation Mediators; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Smoking; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2012 |